Health-care companies rose amid hopes for more lucrative drug developments. Roche rallied after the Swiss drug maker said its fenebrutinib drug candidate met primary goals in two late-stage trials for ...

Ironwood Pharmaceuticals' shares rose Monday after the company raised its full-year revenue guidance, following strong third-quarter results helped by higher prescription demand. Shares rose 27% to $2 ...

The mean percentage of calories consumed by adults from ultra-processed foods dropped 3 percentage points from 2018 to 2023, ...

India is witnessing a sharp rise in infectious diseases, with one in nine tests coming positive for dengue and influenza A, ...

It is good that Brussels has recognised that this is an issue not just here in Ireland, but in other member states — such as ...

Equities broadly ended higher, with some reaching record levels, contributing to strong year-to-date performance. Read more ...

Dominic Cipriano couldn't stop shaking. A drug dealer on the streets of Kensington had sold him a bag of what he thought was ...

The latest data on the burden of chronic kidney disease (CKD) in South Asia, indicating that 16% of the population is ...

Mycoplasma pneumoniae infections have risen significantly post-COVID-19, presenting with both respiratory and increasing ...

Despite five heart attacks, multiple surgeries and a heart transplant, Cheney still lived a long life and died surrounded by ...

Our prediction model provides a useful framework for conveying tailored risk information simply and identifying women who may receive enhanced benefit from specific intervention strategies because ...

Report is The Hill’s midday newsletter. Subscribe here. Happy Thursday. Thanksgiving is three weeks from today! But don’t ...